Rome, Italy

Rita Scarpelli

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 152(Granted Patents)


Location History:

  • Pomezia, IT (2011 - 2013)
  • Genoa, IT (2017 - 2018)
  • Rome, IT (2007 - 2020)

Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Meet Rita Scarpelli: An Innovative Inventor from Rome, Italy

Introduction:

Rita Scarpelli, a renowned inventor hailing from Rome, Italy, has made significant contributions to the field of pharmaceutical research. With an impressive portfolio of 21 patents, Scarpelli's innovative mindset and dedication to advancing medical treatments have played a pivotal role in shaping the industry. This article provides insights into Scarpelli's latest patents, career highlights, notable collaborations, and her unwavering commitment to innovation.

Latest Patents:

Scarpelli's recent patents demonstrate her expertise in developing novel therapeutic approaches. Two notable patents are worth mentioning. Firstly, the patent on "Piperazinyl methanone NAAA inhibitors" explores compositions and methods that modulate the activity of N-acylethanolamine acid amidase, thus offering potential treatments for various pathological states such as pain, inflammation, and neurodegenerative disorders. Secondly, Scarpelli's patent on "Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments" presents compositions and methods for inhibiting fatty acid amide hydrolase, providing opportunities for advanced medicinal interventions.

Career Highlights:

Scarpelli's innovative journey began with her tenure at Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. During her time there, she made significant strides in drug discovery and development, leading to numerous patent applications. Her expertise and dedication to advancing scientific research earned her a prominent position within the company.

Later, Scarpelli became associated with the Fondazione Istituto Italiano Di Tecnologia, enhancing her reputation as a visionary inventor. Her relentless pursuit of breakthrough solutions contributed to the foundation's mission of promoting technological advancements in diverse fields.

Collaborations:

Throughout her career, Scarpelli has had the opportunity to collaborate with esteemed professionals, further enriching her inventive endeavors. Notable colleagues include Philip Jones and Ester Muraglia, who share her passion for scientific exploration. Together, they have worked on various projects aimed at revolutionizing the pharmaceutical landscape, focusing on drug target identification and therapeutic intervention.

Conclusion:

Rita Scarpelli's impressive repertoire of patents and remarkable professional journey exemplify her unwavering commitment to innovation within the pharmaceutical industry. Her groundbreaking inventions, including the development of N-acylethanolamine acid amidase modulators and fatty acid amide hydrolase inhibitors, highlight her dedication to advancing medical treatments for numerous pathological states. Collaborating with esteemed professionals has further amplified her ability to create transformative solutions. As a leading figure in the field, Scarpelli continues to inspire and revolutionize the world of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…